{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:48:05Z","timestamp":1774126085768,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:00:00Z","timestamp":1188259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2334-7-99","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T18:12:39Z","timestamp":1188324759000},"source":"Crossref","is-referenced-by-count":45,"title":["Utility of interferon-\u03b3 ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa"],"prefix":"10.1186","volume":"7","author":[{"given":"Stephen D","family":"Lawn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonzwakazi","family":"Bangani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motasim","family":"Badri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Ntobongwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,28]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nri1704","volume":"5","author":"P Nunn","year":"2005","unstructured":"Nunn P, Williams B, Floyd K, Dye C, Elzinga G, Raviglione M: Tuberculosis control in the era of HIV. Nat Rev Immunol. 2005, 5: 819-826. 10.1038\/nri1704.","journal-title":"Nat Rev Immunol"},{"key":"542_CR2","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1086\/501018","volume":"42","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R: Impact of HIV Infection on the Epidemiology of Tuberculosis in a Peri-Urban Community in South Africa: The Need for Age-Specific Interventions. Clin Infect Dis. 2006, 42: 1040-1047. 10.1086\/501018.","journal-title":"Clin Infect Dis"},{"key":"542_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.200606-759OC","volume":"175","author":"R Wood","year":"2007","unstructured":"Wood R, Middelkoop K, Myer L, Grant AD, Whitelaw A, Lawn SD, Kaplan G, Huebner R, McIntyre J, Bekker LG: Undiagnosed tuberculosis in a community with high HIV prevalence: implications for tuberculosis control. Am J Respir Crit Care Med. 2007, 175: 87-93. 10.1164\/rccm.200606-759OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"542_CR4","volume-title":"WHO declares TB an emergency in Africa.Call for \"urgent and extraordinary actions\" to halt a worsening epidemic.2nd September 2005 http:\/\/www.who.int\/mediacentre\/news\/2005\/africa_emergency\/en\/ accessed 6\/9\/2005","author":"WH Organisation","year":"2005","unstructured":"Organisation WH: WHO declares TB an emergency in Africa.Call for \"urgent and extraordinary actions\" to halt a worsening epidemic.2nd September 2005 http:\/\/www.who.int\/mediacentre\/news\/2005\/africa_emergency\/en\/ accessed 6\/9\/2005. 2005"},{"key":"542_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"M Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JM: Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis. 2004, 4: 761-776. 10.1016\/S1473-3099(04)01206-X.","journal-title":"Lancet Infect Dis"},{"key":"542_CR6","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/IAI.63.5.1710-1717.1995","volume":"63","author":"AL Sorensen","year":"1995","unstructured":"Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB: Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 1995, 63: 1710-1717.","journal-title":"Infect Immun"},{"key":"542_CR7","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","volume":"144 ( Pt 11)","author":"FX Berthet","year":"1998","unstructured":"Berthet FX, Rasmussen PB, Rosenkrands I, Andersen P, Gicquel B: A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology. 1998, 144 ( Pt 11): 3195-3203.","journal-title":"Microbiology"},{"key":"542_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/IAI.64.1.16-22.1996","volume":"64","author":"M Harboe","year":"1996","unstructured":"Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P: Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996, 64: 16-22.","journal-title":"Infect Immun"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/S0140-6736(00)05115-1","volume":"357","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, Reece WH, Latif M, Pasvol G, Hill AV: Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 2001, 357: 2017-2021. 10.1016\/S0140-6736(00)05115-1.","journal-title":"Lancet"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","volume":"361","author":"K Ewer","year":"2003","unstructured":"Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A: Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003, 361: 1168-1173. 10.1016\/S0140-6736(03)12950-9.","journal-title":"Lancet"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","volume":"163","author":"A Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, Pasvol G, Hill AV: Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med. 2001, 163: 824-828.","journal-title":"Am J Respir Crit Care Med"},{"key":"542_CR12","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","volume":"364","author":"S Liebeschuetz","year":"2004","unstructured":"Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A: Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet. 2004, 364: 2196-2203. 10.1016\/S0140-6736(04)17592-2.","journal-title":"Lancet"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","volume":"167","author":"AA Pathan","year":"2001","unstructured":"Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, Lalvani A: Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol. 2001, 167: 5217-5225.","journal-title":"J Immunol"},{"key":"542_CR14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2334-6-66","volume":"6","author":"AM Aiken","year":"2006","unstructured":"Aiken AM, Hill PC, Fox A, McAdam KP, Jackson-Sillah D, Lugos MD, Donkor SA, Adegbola RA, Brookes RH: Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis. 2006, 6: 66-10.1186\/1471-2334-6-66.","journal-title":"BMC Infect Dis"},{"key":"542_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/427030","volume":"40","author":"PC Hill","year":"2005","unstructured":"Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Corrah T, Adegbola RA, McAdam KP, Brookes RH: Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis. 2005, 40: 273-278. 10.1086\/427030.","journal-title":"Clin Infect Dis"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1086\/381754","volume":"38","author":"S Carrara","year":"2004","unstructured":"Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D: Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004, 38: 754-756. 10.1086\/381754.","journal-title":"Clin Infect Dis"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","volume":"70","author":"HM Vordermeier","year":"2002","unstructured":"Vordermeier HM, Chambers MA, Cockle PJ, Whelan AO, Simmons J, Hewinson RG: Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002, 70: 3026-3032. 10.1128\/IAI.70.6.3026-3032.2002.","journal-title":"Infect Immun"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/507427","volume":"194","author":"D Goletti","year":"2006","unstructured":"Goletti D, Butera O, Bizzoni F, Casetti R, Girardi E, Poccia F: Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis. 2006, 194: 984-992. 10.1086\/507427.","journal-title":"J Infect Dis"},{"key":"542_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","author":"AL Chapman","year":"2002","unstructured":"Chapman AL, Munkanta M, Wilkinson KA, Pathan AA, Ewer K, Ayles H, Reece WH, Mwinga A, Godfrey-Faussett P, Lalvani A: Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS. 2002, 16: 2285-2293. 10.1097\/00002030-200211220-00008.","journal-title":"AIDS"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1164\/rccm.200610-1439OC","volume":"175","author":"MX Rangaka","year":"2007","unstructured":"Rangaka MX, Wilkinson KA, Seldon R, Van CG, Meintjes GA, Morroni C, Mouton P, Diwakar L, Connell TG, Maartens G, Wilkinson RJ: Effect of HIV-1 Infection on T-Cell-based and Skin Test Detection of Tuberculosis Infection. Am J Respir Crit Care Med. 2007, 175: 514-520. 10.1164\/rccm.200610-1439OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"542_CR21","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/518234","volume":"44","author":"MX Rangaka","year":"2007","unstructured":"Rangaka MX, Diwakar L, Seldon R, Van CG, Meintjes GA, Morroni C, Mouton P, Shey MS, Maartens G, Wilkinson KA, Wilkinson RJ: Clinical, immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected Africans. Clin Infect Dis. 2007, 44: 1639-1646. 10.1086\/518234.","journal-title":"Clin Infect Dis"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","volume":"20","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R: Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006, 20: 1605-1612.","journal-title":"AIDS"},{"key":"542_CR23","first-page":"315","volume":"96","author":"LG Bekker","year":"2006","unstructured":"Bekker LG, Myer L, Orrell C, Lawn S, Wood R: Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J. 2006, 96: 315-320.","journal-title":"S Afr Med J"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","volume":"19","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Myer L, Orrell C, Bekker LG, Wood R: Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005, 19: 2141-2148.","journal-title":"AIDS"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/507095","volume":"43","author":"SD Lawn","year":"2006","unstructured":"Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R: Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006, 43: 770-776. 10.1086\/507095.","journal-title":"Clin Infect Dis"},{"key":"542_CR26","unstructured":"Control CTTB: Progress report 1997-2003. Health Systems Trust, Cape Town, South Africa, 2004. http:\/\/www.hst.org.za."},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.trstmh.2004.01.007","volume":"98","author":"AM Elliott","year":"2004","unstructured":"Elliott AM, Hodsdon WS, Kyosiimire J, Quigley MA, Nakiyingi JS, Namujju PB, Watera C, French N, Gilks CF, Dockrell HM, Whitworth JA: Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg. 2004, 98: 660-670.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"542_CR28","first-page":"664","volume":"5","author":"GF Black","year":"2001","unstructured":"Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, Blackwell JM, Bliss L, Sichali L, Mwaungulu L, Chaguluka S, Jarman E, Ngwira B, Dockrell HM: Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis. 2001, 5: 664-672.","journal-title":"Int J Tuberc Lung Dis"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","volume":"359","author":"GF Black","year":"2002","unstructured":"Black GF, Weir RE, Floyd S, Bliss L, Warndorff DK, Crampin AC, Ngwira B, Sichali L, Nazareth B, Blackwell JM, Branson K, Chaguluka SD, Donovan L, Jarman E, King E, Fine PE, Dockrell HM: BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002, 359: 1393-1401. 10.1016\/S0140-6736(02)08353-8.","journal-title":"Lancet"},{"key":"542_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/426139","volume":"40","author":"KA Wilkinson","year":"2005","unstructured":"Wilkinson KA, Wilkinson RJ, Pathan A, Ewer K, Prakash M, Klenerman P, Maskell N, Davies R, Pasvol G, Lalvani A: Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis. 2005, 40: 184-187. 10.1086\/426139.","journal-title":"Clin Infect Dis"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nri778","volume":"2","author":"SM Kaech","year":"2002","unstructured":"Kaech SM, Wherry EJ, Ahmed R: Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. 2002, 2: 251-262. 10.1038\/nri778.","journal-title":"Nat Rev Immunol"},{"key":"542_CR32","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/323044","volume":"33","author":"BA Wu-Hsieh","year":"2001","unstructured":"Wu-Hsieh BA, Chen CK, Chang JH, Lai SY, Wu CH, Cheng WC, Andersen P, Doherty TM: Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis. 2001, 33: 1336-1340. 10.1086\/323044.","journal-title":"Clin Infect Dis"},{"key":"542_CR33","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1164\/rccm.200608-1088OC","volume":"175","author":"AF Luetkemeyer","year":"2007","unstructured":"Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV: Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med. 2007, 175: 737-742. 10.1164\/rccm.200608-1088OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"542_CR34","volume-title":"Program & Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections February","author":"J Elliott","year":"2007","unstructured":"Elliott J, Sarun S, Chin S, Chel S, Huffman S, Saphonn V, Kaldor J, French M, Cooper D, Mean C: Performance characteristics of a whole blood interferon-gamma release assay in HIV patients commencing ART in a high TB incidence setting. Program & Abstracts of the 14th Conference on Retroviruses and Opportunistic Infections February. 2007, Los Angeles, CA, USA Abstract #859"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1073\/pnas.87.6.2379","volume":"87","author":"N Oyaizu","year":"1990","unstructured":"Oyaizu N, Chirmule N, Kalyanaraman VS, Hall WW, Pahwa R, Shuster M, Pahwa S: Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci U S A. 1990, 87: 2379-2383. 10.1073\/pnas.87.6.2379.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"542_CR36","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/0042-6822(92)90275-T","volume":"191","author":"SB Miller","year":"1992","unstructured":"Miller SB, Tse H, Rosenspire AJ, King SR: CD4-independent inhibition of lymphocyte proliferation mediated by HIV-1 envelope glycoproteins. Virology. 1992, 191: 973-977. 10.1016\/0042-6822(92)90275-T.","journal-title":"Virology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-7-99\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-7-99.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T05:20:00Z","timestamp":1587878400000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-7-99"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-7-99","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,28]]},"article-number":"99"}}